MB Endometodas
JAR Code: 306282890
LIQUIDATINGFinancial Reports
| 2023 | 2024 | ||
|---|---|---|---|
| Revenue | 2 453 | 4 687 | |
| Profit Before Tax | 1 700 | −2 228 | |
| Net Profit | 1 700 | −2 228 | |
| Profit margin | 69.3% | -47.5% | |
| Equity | 2 700 | 472 | |
| Liabilities | 24 | 344 | |
| Total Assets | 2 724 | 816 |
Financial Reports
2024
Balance Sheet
Total Assets816 €
Long-term Assets0 €
Short-term Assets816 €
Equity472 €
Liabilities344 €
Profit & Loss Statement
Revenue4 687 €
Profit Before Tax−2 228 €
Net Profit−2 228 €
2023(2023-03-27 – 2023-12-31)9 mėn.
Balance Sheet
Total Assets2 724 €
Long-term Assets0 €
Short-term Assets2 724 €
Equity2 700 €
Liabilities24 €
Profit & Loss Statement
Revenue2 453 €
Profit Before Tax1 700 €
Net Profit1 700 €
Source: Registrų centras